CARBIOS Active has also been certified by the BPI. Credit: Carbios/GlobeNewswire.

Biotech company Carbios has announced the inclusion of its enzymatic solution, CARBIOS Active, in the US Food and Drug Administration (FDA) Inventory of Effective Food Contact Substances (FCS). 

The solution was assigned Food Contact Notification (FCN) 2325 effective 29 February 2024.  

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

This inclusion allows the use of CARBIOS Active in the manufacture of food-grade packaging materials in the US, including both rigid and flexible applications, among others.

The integration of this solution into plastic conversion processes facilitates the production of a new generation of polylactic acid (PLA) that is fully compostable at ambient temperatures, without leaving behind toxic residues or microplastics. 

PLA-based plastics incorporating CARBIOS Active are certified for both industrial and home composting.  

See Also:

The Biodegradable Products Institute (BPI), an authority in North America on compostable products and packaging, has also certified CARBIOS Active.  

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Carbios CEO Emmanuel Ladent said: “For Carbios, product safety is of utmost priority and we consider FCN from the FDA as the gold standard.  

“The US is a key market for Carbios’ biodegradation solution and we expect the FCN clearance to drive significant additional demand in North America in 2024. Well done to the teams from our biodegradation division for their relentless efforts.” 

Last month, Carbios partnered with engineering, procurement and construction services provider De Smet Engineers & Contractors to construct a polyethylene terephthalate biorecycling plant in France.